
Trump Administration Executive Order (EO) Tracker
Lowell M. Zeta
Partner Global Regulatory
He counsels extensively on product quality, safety, and compliance with current good manufacturing practice (GMP) requirements and data integrity standards for clinical and commercial stage products, focusing on next generation products with complex manufacturing and global supply chain considerations. He is at the forefront of the industry's digital transformation initiatives and advises on AI and enabling technologies and innovative data strategies, drug development tools and innovative biomarkers, real-world evidence (RWE) platforms, advanced manufacturing, and supply chain resilience.
He works closely with executive leadership and risk oversight committees to resolve warning letters and import alerts, and advises on product and compliance-related government and internal investigations, global corporate compliance programs, commercial manufacturing arrangements, and due diligence in life sciences transactions.
He represents FDA-regulated companies in government and commercial litigation involving FDA regulated products, including negotiations with DOJ/FDA regarding injunctions and consent decrees related to product quality and market access issues, legal challenges to agency decisions under the Administrative Procedure Act (APA), and commercial disputes under the Lanham Act and state consumer protection laws.